Patent · US Active

Glucagon/GLP-1 receptor co-agonists

US9309301B2 · kind B2 · utility

1Cited by
17References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 12, 2012
Grant dateApr 12, 2016
Priority date—
Expiry dateAug 16, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/2835
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are peptides and variant peptides that exhibit enhanced activity at the GLP-1 receptor, as compared to native glucagon.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.